Lexicon Pharmaceutcl (LXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,063 | -23,476 | -87,758 | -62,147 | -39,025 |
| Depreciation Amortization | 395 | 134 | 346 | 226 | 108 |
| Accounts receivable | -20 | -23 | 381 | 372 | 236 |
| Accounts payable and accrued liabilities | -5,447 | -3,308 | -14,158 | -13,433 | -14,707 |
| Other Working Capital | -5,779 | -2,851 | -10,231 | -10,617 | -13,759 |
| Other Operating Activity | 11,071 | 6,103 | 24,403 | 21,410 | 20,108 |
| Operating Cash Flow | $-47,843 | $-23,421 | $-87,017 | $-64,189 | $-47,039 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -17,980 | -4,332 | 37,592 | -2,788 | -2,601 |
| PPE Investments | -76 | -76 | -1,221 | -1,198 | -985 |
| Purchase Of Investment | N/A | N/A | -34,261 | N/A | N/A |
| Investing Cash Flow | $-18,056 | $-4,408 | $2,110 | $-3,986 | $-3,586 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 24,148 | 24,148 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | -11,700 | N/A | N/A |
| Common Stock Issued | N/A | N/A | 37,084 | 36,705 | 16,924 |
| Common Stock Repurchased | -864 | -864 | -2,675 | -2,675 | -2,675 |
| Financing Cash Flow | $23,284 | $23,284 | $22,709 | $34,030 | $14,249 |
| Beginning Cash Position | 64,065 | 64,065 | 126,263 | 126,263 | 126,263 |
| End Cash Position | 21,450 | 59,520 | 64,065 | 92,118 | 89,887 |
| Net Cash Flow | $-42,615 | $-4,545 | $-62,198 | $-34,145 | $-36,376 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,843 | -23,421 | -87,017 | -64,189 | -47,039 |
| Capital Expenditure | -76 | -76 | -1,221 | -1,198 | -985 |
| Free Cash Flow | -47,919 | -23,497 | -88,238 | -65,387 | -48,024 |